JANE STREET GROUP, LLC - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 49 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$22,298
-9.9%
17,285
-7.8%
0.00%
Q2 2023$24,745
-61.6%
18,746
-79.4%
0.00%
Q1 2023$64,394
-55.5%
91,093
-52.8%
0.00%
Q4 2022$144,722
-3.5%
192,962
+11.0%
0.00%
Q3 2022$150,000
+500.0%
173,786
+689.1%
0.00%
Q2 2022$25,000
-84.3%
22,024
-53.4%
0.00%
Q1 2021$159,000
+93.9%
47,219
+105.0%
0.00%
Q4 2020$82,00023,0380.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2020
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,048,757$6,904,0002.75%
Asymmetry Capital Management, L.P. 1,063,264$3,583,0001.85%
Endurant Capital Management LP 1,339,835$4,515,0001.18%
Altium Capital Management LP 1,250,000$4,213,0001.17%
Affinity Asset Advisors, LLC 900,000$3,033,0001.03%
DAFNA Capital Management LLC 1,249,648$4,211,0001.00%
Boxer Capital, LLC 6,226,673$20,984,0000.71%
Delphi Management Partners VIII, L.L.C. 256,734$865,0000.60%
Rubric Capital Management LP 2,914,861$9,823,0000.57%
Orbimed Advisors 17,264,763$58,183,0000.54%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders